Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

KAL1 Antikörper (N-Term)

KAL1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated

Produktnummer ABIN2294706

Datenblatt (PDF)

Target Alle KAL1 Antikörper anzeigen

KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
Bindungsspezifität
15

2

1

1

1

1

1

1

1
AA 165-194, N-Term
Reaktivität
30

1

1
Human
Wirt
28

2
Kaninchen
Passende Sekundärantikörper
Klonalität
29

1
Polyklonal
Konjugat
10

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Dieser KAL1 Antikörper ist unkonjugiert
Applikation
23

13

13

8

3

3

3

1

1

1
Western Blotting (WB), ELISA

Kreuzreaktivität

Human

Kreuzreaktivität (Details)

Calculated cross reactivity: Hu

Produktmerkmale

KAL1, NT (KAL1, ADMLX, KAL, KALIG1, Anosmin-1, Adhesion molecule-like X-linked, Kallmann syndrome protein)

Aufreinigung

Purified by Protein A affinity chromatography.

Immunogen

KAL1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 165-194 amino acids from the N-terminal region of human KAL1.

Isotyp

IgG

Top Product

Discover our top product KAL1 Primärantikörper
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 200-300) antibody
KAL1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Kallmann Syndrome 1 Sequence (KAL1) antibody
KAL1 Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated

anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibody
KAL1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated

anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibody
KAL1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E8 unconjugated

anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 166-194), (N-Term) antibody
KAL1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB39497 unconjugated

anti-Kallmann Syndrome 1 Sequence (KAL1) (Internal Region) antibody
KAL1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated

anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 131-230) antibody
KAL1 Reaktivität: Human WB, ELISA, IF (cc), IF (p), IHC (fro), IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 131-230) antibody (Biotin)
KAL1 Reaktivität: Human WB, ELISA, IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal Biotin

anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 131-230) antibody (AbBy Fluor® 350)
KAL1 Reaktivität: Human WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal AbBy Fluor® 350

anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 131-230) antibody (AbBy Fluor® 488)
KAL1 Reaktivität: Human WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal AbBy Fluor® 488

Applikationshinweise

Optimal working conditions should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Liquid

Buffer

Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung

-20 °C

Informationen zur Lagerung

-20°C
Target

KAL1 (Kallmann Syndrome 1 Sequence (KAL1))

Andere Bezeichnung

KAL1 (KAL1 Produkte)

NCBI Accession

NP_000207

UniProt

P23352